Vendome Acquisition Corp I（VNME）の株式分析

AI分析 of Vendome Acquisition Corp I (VNME)

中立

Currently, VNME is trading at $10.34, which is at its 52-week high of $10.34, indicating it may be overvalued at this price point. The RSI is at 59.82, suggesting it is approaching overbought territory. While the company has shown a positive trend with a 1-year change of +3.19%, the lack of significant net income and a forward P/E ratio of 0 indicates uncertainty about future profitability. The main risk is the high price-to-book ratio of 1074.59, which suggests that the stock is significantly overvalued compared to its book value. Overall, it may be prudent to hold off on buying until a more favorable entry point is identified.

バリュエーション指標

Vendome Acquisition Corp I（VNME）の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E

現在のP/E

0.00

予想EV/EBITDA

5年平均 EV/EBITDA

現在のEV/EBITDA

0.00

予想PSR

5年平均 P/S

現在のP/S

0.00

VNME を保有するクジラ

M

Magnetar Capital Partners, LP

+ を保有VNME

+1.44%

3か月リターン

C

Centiva Capital, LP

+ を保有VNME

-5.26%

3か月リターン

VNME のよくある質問 — Alphio AI が回答

Vendome Acquisition Corporation I is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific Business Combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has no operations and has generated no revenues. It operates in the Financials sector.

Currently, VNME is trading at $10.34, which is at its 52-week high of $10.34, indicating it may be overvalued at this price point. The RSI is at 59.82, suggesting it is approaching overbought territory. While the company has shown a positive trend with a 1-year change of +3.19%, the lack of significant net income and a forward P/E ratio of 0 indicates uncertainty about future profitability. The main risk is the high price-to-book ratio of 1074.59, which suggests that the stock is significantly overvalued compared to its book value. Overall, it may be prudent to hold off on buying until a more favorable entry point is identified.